Insulin-resistance-associated compensatory mechanisms of pancreatic beta cells: A current opinion

Frontiers in Endocrinology

Volumn 4, Issue OCT, 2013, Pages

  Araújo, Tiago G ^a   Oliveira, Alexandre G ^a   Saad, Mario J A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Beta cells; Betatrophin; Diabetes mellitus; Hgf; Insulin resistance; Liver; Obesity

Indexed keywords

GROWTH HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; PROLACTIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SOMATOMEDIN C;

CELL PROLIFERATION; HUMAN; HYPERPLASIA; INSULIN RESISTANCE; MICROARRAY ANALYSIS; NONHUMAN; NOTE; OBESITY; PANCREAS ISLET BETA CELL; SIGNAL TRANSDUCTION;

EID: 84893045655     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00146     Document Type: Note

References (12)

1. Flier SN, Kulkarni RN, Kahn CR. Evidence for a cir-culating islet cell growth factor in insulin-resistant states. Proc Natl Acad Sci U S A (2001) 98(13):7475- 80. doi: 10.1073/pnas.131192998
2. El Ouaamari A, Kawamori D, Dirice E, Liew CW, Shadrach JL, Hu J, et al. Liver-derived systemic fac-tors drive beta cell hyperplasia in insulin-resistant states. Cell Rep (2013) 3(2):401-10. doi: 10.1016/j. celrep.2013.01.007
3. Ashcroft FM, Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell (2012) 148(6):1160- 71. doi: 10.1016/j.cell.2012.02.010
4. Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA, Butler PC. Beta-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care (2013) 36(1):111-7. doi: 10.2337/dc12-0421
5. Bonner-Weir S, Smith FE. Islet cell growth and the growth factors involved. Trends Endocrinol Metab (1994) 5(2):60-4. doi: 10.1016/1043-2760(94)90003-5
6. Araujo TG, Oliveira AG, Carvalho BM, Guadagnini D, Protzek AO, Carvalheira JB, et al. Hepatocyte growth factor plays a key role in insulin resist-ance-associated compensatory mechanisms. Endocrinology (2012) 153(12):5760-9. doi: 10.1210/ en.2012-1496
7. Imai J, Katagiri H, Yamada T, Ishigaki Y, Suzuki T, Kudo H, et al. Regulation of pancreatic beta cell mass by neuronal signals from the liver. Science (2008) 322(5905):1250-4. doi: 10.1126/ science.1163971
8. Yi P, Park JS, Melton DA. Betatrophin: a hor-mone that controls pancreatic beta cell prolif-eration. Cell (2013) 153(4):747-58. doi: 10.1016/j. cell.2013.04.008
9. Kinsey-Jones JS, Murphy KG. Current models and strategies in the development of antiobesity drugs. Ann N Y Acad Sci (2011) 1245:3-6. doi: 10.1111/j.1749-6632.2011.06343.x
10. Nilsson C, Raun K, Yan FF, Larsen MO, Tang- Christensen M. Laboratory animals as surrogate models of human obesity. Acta Pharmacol Sin (2012) 33(2):173-81. doi: 10.1038/aps.2011.203
11. Kim A, Miller K, Jo J, Kilimnik G, Wojcik P, Hara M. Islet architecture: a comparative study. Islets (2009) 1(2):129-36. doi: 10.4161/isl.1.2.9480
12. Yan SQ, Lin HZ, Hwang JW, Chacko VP, Diehl AM. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res (2001) 61(13):5016-23.